HIV 1 Infection

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

Study of GS-0415 and How It Works in People With HIV

Safety Study of MucoCept-CVN

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life

Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life (2)

Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study

PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY

HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study

Analyses of Newly Diagnosed HIV Infection in Hong Kong

Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure

Impacts of HIV Treatment Regimens on Archived Drug Resistance

Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil

Integrating iSYV Within HIV Clinical Care for Youth Living With HIV in Tanzania

Combining Latency Reversing Agents to Address the HIV Reservoir

Prevention ICONA Dedicated Ensemble

Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine